Hetzel B S
Postgrad Med J. 1968 May;44(511):363-76. doi: 10.1136/pgmj.44.511.363.
Studies of thyroid stimulating activity of serum from thyrotoxic patients has revealed an abnormal prolonged response in the mouse present in 40-60% of patients depending on the criteria used. This agent designated long acting thyroid stimulator (LATS) is a 7S globulin. Transplacental passage of LATS accounts for neonatal thyrotoxicosis—a self-limited disease. LATS is also more readily detected in patients with large goitre, exophthalmos, pretibial myxoedema and recurrence following therapy. Thyroid ablation is usually followed by a fall in the level of LATS. A fall may also be produced by steroid therapy or immunosuppressive agents. LATS probably arises from lymphoid tissue which accounts for the non-suppressibility of the hypersecreting thyroid. Its discovery provides strong evidence that hyperthyroidism is often, though not always, a disorder of immunological tolerance.
对甲状腺毒症患者血清促甲状腺活性的研究表明,根据所采用的标准,40%至60%的患者体内存在一种异常的、在小鼠中持续时间延长的反应。这种被称为长效甲状腺刺激素(LATS)的物质是一种7S球蛋白。LATS经胎盘传递可导致新生儿甲状腺毒症——一种自限性疾病。在患有大甲状腺肿、突眼、胫前黏液性水肿以及治疗后复发的患者中,LATS也更容易被检测到。甲状腺切除术后,LATS水平通常会下降。类固醇疗法或免疫抑制剂也可能导致其水平下降。LATS可能源自淋巴组织,这解释了甲状腺分泌过多的不可抑制性。它的发现提供了强有力的证据,表明甲状腺功能亢进症虽然并非总是,但常常是一种免疫耐受紊乱。